Localised prostate cancer patients may maintain quality of life, experience low toxicity after SBRT.

MedWire (3/3, Taylor) reported, "Stereotactic body radiotherapy (SBRT) achieves low toxicity and maintains quality of life (QoL) in patients with localised prostate cancer," according to a paper in Biomed Central Urology. Researchers at the Winthrop University Hospital explained that "at a median 30-month follow-up for the 35-Gy level, the long-term urinary and rectal toxicity are both low."

In addition the responses to the Expanded Prostate Cancer Index Composite "questionnaires...suggest that urinary, rectal and sexual QoL following SBRT may be comparable, if not better than that for external beam radiotherapy, brachytherapy, and radical prostatectomy."

http://www.biomedcentral.com/1471-2490/10/1/abstract

Other News

Next Article